These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 23388123)

  • 1. Clinicopathologic analysis of combined hepatocellular-cholangiocarcinoma according to the latest WHO classification.
    Akiba J; Nakashima O; Hattori S; Tanikawa K; Takenaka M; Nakayama M; Kondo R; Nomura Y; Koura K; Ueda K; Sanada S; Naito Y; Yamaguchi R; Yano H
    Am J Surg Pathol; 2013 Apr; 37(4):496-505. PubMed ID: 23388123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The utility of keratin 903 as a new prognostic marker in mass-forming-type intrahepatic cholangiocarcinoma.
    Aishima S; Asayama Y; Taguchi K; Sugimachi K; Shirabe K; Shimada M; Sugimachi K; Tsuneyoshi M
    Mod Pathol; 2002 Nov; 15(11):1181-90. PubMed ID: 12429797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High mobility group A1 is expressed in metastatic adenocarcinoma to the liver and intrahepatic cholangiocarcinoma, but not in hepatocellular carcinoma: its potential use in the diagnosis of liver neoplasms.
    Abe N; Watanabe T; Izumisato Y; Suzuki Y; Masaki T; Mori T; Sugiyama M; Fusco A; Atomi Y
    J Gastroenterol; 2003; 38(12):1144-9. PubMed ID: 14714251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A mixed hepatocellular carcinoma and cholangiocarcinoma: dual expression of biliary-type cytokeratin and hepatocyte specific marker.
    Tanaka S; Hirohashi K; Uenishi T; Yamamoto T; Hamba H; Kubo S; Tanaka H; Shuto T; Ogawa M; Kinoshita H
    Hepatogastroenterology; 2004; 51(57):839-41. PubMed ID: 15143930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of Glut-1 expression in cholangiocarcinoma, benign biliary lesions and hepatocellular carcinoma.
    Zimmerman RL; Fogt F; Burke M; Murakata LA
    Oncol Rep; 2002; 9(4):689-92. PubMed ID: 12066193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinicopathologic features and diagnosis of mixed type hepatocellular carcinoma].
    Lu J; Lin Z; Yuan S
    Zhonghua Zhong Liu Za Zhi; 1995 May; 17(3):208-11. PubMed ID: 7656828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Histological classification of hepatocellular carcinoma].
    Kojiro M
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():203-15. PubMed ID: 11761942
    [No Abstract]   [Full Text] [Related]  

  • 8. Cholangiocarcinomas arising in cirrhosis and combined hepatocellular-cholangiocellular carcinomas share apomucin profiles.
    Sasaki M; Nakanuma Y; Ho SB; Kim YS
    Am J Clin Pathol; 1998 Mar; 109(3):302-8. PubMed ID: 9495202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary liver cancer with dual expression of hepatocyte and bile duct epithelial markers.
    Uenishi T; Hirohashi K; Shuto T; Tsukamoto T; Yamamoto T; Ogawa M; Kubo S; Tanaka H; Kinoshita H
    Hepatogastroenterology; 2002; 49(46):1092-4. PubMed ID: 12143210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocarcinoma-intestine-pancreas/pancreatic associated protein (HIP/PAP) is expressed and secreted by proliferating ductules as well as by hepatocarcinoma and cholangiocarcinoma cells.
    Christa L; Simon MT; Brezault-Bonnet C; Bonte E; Carnot F; Zylberberg H; Franco D; Capron F; Roskams T; Bréchot C
    Am J Pathol; 1999 Nov; 155(5):1525-33. PubMed ID: 10550309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary liver carcinoma in genetic hemochromatosis reveals a broad histologic spectrum.
    Morcos M; Dubois S; Bralet MP; Belghiti J; Degott C; Terris B
    Am J Clin Pathol; 2001 Nov; 116(5):738-43. PubMed ID: 11710692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic classification of combined hepatocellular-cholangiocarcinoma.
    Fujii H; Zhu XG; Matsumoto T; Inagaki M; Tokusashi Y; Miyokawa N; Fukusato T; Uekusa T; Takagaki T; Kadowaki N; Shirai T
    Hum Pathol; 2000 Sep; 31(9):1011-7. PubMed ID: 11014564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synchronous hepatocellular carcinoma and cholangiocarcinoma arising in two different dysplastic nodules.
    Kwon Y; Lee SK; Kim JS; Ro JY; Yu E
    Mod Pathol; 2002 Oct; 15(10):1096-101. PubMed ID: 12379757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathologic features and prognosis of combined hepatocellular cholangiocarcinoma.
    Koh KC; Lee H; Choi MS; Lee JH; Paik SW; Yoo BC; Rhee JC; Cho JW; Park CK; Kim HJ
    Am J Surg; 2005 Jan; 189(1):120-5. PubMed ID: 15701504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of MUC1 and MUC2 mucin antigens in intrahepatic bile duct tumors: its relationship with a new morphological classification of cholangiocarcinoma.
    Higashi M; Yonezawa S; Ho JJ; Tanaka S; Irimura T; Kim YS; Sato E
    Hepatology; 1999 Dec; 30(6):1347-55. PubMed ID: 10573510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined hepatocellular and cholangiocarcinoma: proposed criteria according to cytokeratin expression and analysis of clinicopathologic features.
    Maeda T; Adachi E; Kajiyama K; Sugimachi K; Tsuneyoshi M
    Hum Pathol; 1995 Sep; 26(9):956-64. PubMed ID: 7545644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Separate histogenesis of combined hepatocellular and cholangiocellular carcinoma in two patients.
    Nagafuchi Y; Okamoto K; Shono M; Higure A; Todoroki H; Itoh H; Takeda S; Katumoto F; Toyoshima S
    Hepatogastroenterology; 1998; 45(20):523-7. PubMed ID: 9638442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hepato-cholangiocarcinoma with diffuse metastases and hypercalcemia].
    Pérez Roldán F; Carretero L; Aguirre A; Bañares R; Casado M; Cos E; Clemente G
    Rev Esp Enferm Dig; 1995 Oct; 87(10):743-7. PubMed ID: 8519543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraperitoneal rupture of cholangiocarcinoma in a patient with liver cirrhosis, type C, with hepatocellular carcinoma.
    Watanabe M; Akagi S; Hamamoto S
    Am J Gastroenterol; 1999 Aug; 94(8):2320-1. PubMed ID: 10445582
    [No Abstract]   [Full Text] [Related]  

  • 20. Diagnostic utility of GLUT1 in the differential diagnosis of liver carcinomas.
    Roh MS; Jeong JS; Kim YH; Kim MC; Hong SH
    Hepatogastroenterology; 2004; 51(59):1315-8. PubMed ID: 15362741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.